Lemaitre Vascular (LMAT) Current Leases (2019 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Current Leases of $3.4 million for Q1 2026, up 30.78% year-over-year from $2.6 million in Q1 2025, and up 17.05% quarter-over-quarter from $2.9 million in Q4 2025.
Lemaitre Vascular (LMAT) Current Leases (2019 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Current Leases for 8 consecutive years, with $3.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 30.78% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (up 30.78% YoY), while the FY2025 annual figure was $2.9 million, up 9.81% from the prior year.
- Current Leases advanced to $3.4 million in Q1 2026 per LMAT's latest filing, from $2.9 million in the prior quarter.
- Across five years, Current Leases topped out at $3.4 million in Q1 2026 and bottomed at $1.8 million in Q2 2022.
- Historically, Current Leases has averaged $2.5 million across 5 years, with a median of $2.6 million in 2024.
- Annual changes were most pronounced in 2022 — Current Leases decreased 8.19% — and 2023, when it soared 50.38%.
- Lemaitre Vascular's Current Leases stood at $1.9 million in 2022, then surged by 31.02% to $2.5 million in 2023, then grew by 8.5% to $2.7 million in 2024, then gained by 9.81% to $2.9 million in 2025, then grew by 17.05% to $3.4 million in 2026.
- Business Quant data shows LMAT's Current Leases at $3.4 million in Q1 2026, $2.9 million in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 29.14 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 20.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | - |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | 3.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.44 Mn |
| Mar 31, 2026 | 3.45 Mn |
| Dec 31, 2025 | 2.94 Mn |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Mar 31, 2025 | 2.64 Mn |
| Dec 31, 2024 | 2.68 Mn |
| Sep 30, 2024 | 2.72 Mn |
| Jun 30, 2024 | 2.59 Mn |
| Mar 31, 2024 | 2.53 Mn |
| Dec 31, 2023 | 2.47 Mn |
| Sep 30, 2023 | 2.75 Mn |
| Jun 30, 2023 | 2.36 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 1.79 Mn |
| Mar 31, 2022 | 1.87 Mn |
| Dec 31, 2021 | 1.87 Mn |
| Sep 30, 2021 | 1.90 Mn |